Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Hypoxia Inducible Factor 1 Alpha Inhibitor

• 1.1 Definition of Hypoxia Inducible Factor 1 Alpha Inhibitor
• 1.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Segment by Type
  • 1.2.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 BC-001
  • 1.2.3 CASI-2ME2
  • 1.2.4 CRLX-101
  • 1.2.5 Others
• 1.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Segment by Applications
  • 1.3.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Solid Tumor
  • 1.3.3 Acute Myelocytic Leukemia
  • 1.3.4 Colorectal Cancer
  • 1.3.5 Others
• 1.4 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Overall Market
  • 1.4.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue (2014-2025)
  • 1.4.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production (2014-2025)
  • 1.4.3 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
  • 1.4.4 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
  • 1.4.5 China Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
  • 1.4.6 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)
  • 1.4.8 India Hypoxia Inducible Factor 1 Alpha Inhibitor Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor
• 2.3 Manufacturing Process Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor
• 2.4 Industry Chain Structure of Hypoxia Inducible Factor 1 Alpha Inhibitor

3 Development and Manufacturing Plants Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Hypoxia Inducible Factor 1 Alpha Inhibitor
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Production and Capacity Analysis
• 4.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue Analysis
• 4.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Price Analysis
• 4.4 Market Concentration Degree

5 Hypoxia Inducible Factor 1 Alpha Inhibitor Regional Market Analysis

• 5.1 Hypoxia Inducible Factor 1 Alpha Inhibitor Production by Regions
  • 5.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production by Regions
  • 5.1.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Regions
• 5.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption by Regions
• 5.3 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
  • 5.3.1 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Production
  • 5.3.2 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
• 5.4 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
  • 5.4.1 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Production
  • 5.4.2 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
• 5.5 China Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
  • 5.5.1 China Hypoxia Inducible Factor 1 Alpha Inhibitor Production
  • 5.5.2 China Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
• 5.6 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
  • 5.6.1 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Production
  • 5.6.2 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
• 5.7 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
  • 5.7.1 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Production
  • 5.7.2 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export
• 5.8 India Hypoxia Inducible Factor 1 Alpha Inhibitor Market Analysis
  • 5.8.1 India Hypoxia Inducible Factor 1 Alpha Inhibitor Production
  • 5.8.2 India Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Hypoxia Inducible Factor 1 Alpha Inhibitor Import and Export

6 Hypoxia Inducible Factor 1 Alpha Inhibitor Segment Market Analysis (by Type)

• 6.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Production by Type
• 6.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Revenue by Type
• 6.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Price by Type

7 Hypoxia Inducible Factor 1 Alpha Inhibitor Segment Market Analysis (by Application)

• 7.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption by Application
• 7.2 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Consumption Market Share by Application (2014-2019)

8 Hypoxia Inducible Factor 1 Alpha Inhibitor Major Manufacturers Analysis

• 8.1 Aileron Therapeutics, Inc.
  • 8.1.1 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
  • 8.1.2 Aileron Therapeutics, Inc. Product Introduction, Application and Specification
  • 8.1.3 Aileron Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 CASI Pharmaceuticals Inc.
  • 8.2.1 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
  • 8.2.2 CASI Pharmaceuticals Inc. Product Introduction, Application and Specification
  • 8.2.3 CASI Pharmaceuticals Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Cerulean Pharma, Inc.
  • 8.3.1 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
  • 8.3.2 Cerulean Pharma, Inc. Product Introduction, Application and Specification
  • 8.3.3 Cerulean Pharma, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 F. Hoffmann-La Roche Ltd.
  • 8.4.1 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
  • 8.4.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
  • 8.4.3 F. Hoffmann-La Roche Ltd. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 InterMed Discovery GmbH
  • 8.5.1 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
  • 8.5.2 InterMed Discovery GmbH Product Introduction, Application and Specification
  • 8.5.3 InterMed Discovery GmbH Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 OncoImmune, Inc.
  • 8.6.1 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
  • 8.6.2 OncoImmune, Inc. Product Introduction, Application and Specification
  • 8.6.3 OncoImmune, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Peloton Therapeutics, Inc.
  • 8.7.1 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
  • 8.7.2 Peloton Therapeutics, Inc. Product Introduction, Application and Specification
  • 8.7.3 Peloton Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 RXi Pharmaceuticals Corporation
  • 8.8.1 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
  • 8.8.2 RXi Pharmaceuticals Corporation Product Introduction, Application and Specification
  • 8.8.3 RXi Pharmaceuticals Corporation Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Sorrento Therapeutics, Inc.
  • 8.9.1 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
  • 8.9.2 Sorrento Therapeutics, Inc. Product Introduction, Application and Specification
  • 8.9.3 Sorrento Therapeutics, Inc. Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Transcriptogen Ltd
  • 8.10.1 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production Sites and Area Served
  • 8.10.2 Transcriptogen Ltd Product Introduction, Application and Specification
  • 8.10.3 Transcriptogen Ltd Hypoxia Inducible Factor 1 Alpha Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Vascular Biogenics Ltd.

9 Development Trend of Analysis of Hypoxia Inducible Factor 1 Alpha Inhibitor Market

• 9.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Trend Analysis
  • 9.1.1 Global Hypoxia Inducible Factor 1 Alpha Inhibitor Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Hypoxia Inducible Factor 1 Alpha Inhibitor Regional Market Trend
  • 9.2.1 North America Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
  • 9.2.2 Europe Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
  • 9.2.3 China Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
  • 9.2.4 Japan Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
  • 9.2.5 Southeast Asia Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
  • 9.2.6 India Hypoxia Inducible Factor 1 Alpha Inhibitor Forecast 2019-2025
• 9.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Trend (Product Type)
• 9.4 Hypoxia Inducible Factor 1 Alpha Inhibitor Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Hypoxia Inducible Factor 1 Alpha Inhibitor Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List